Macular OCT's Proficiency in Identifying Retrochiasmal Visual Pathway Lesions in Multiple Sclerosis—A Pilot Study

Larisa Cujbă,Ana Banc,Cristina Stan,Tudor Drugan,Cristina Nicula
DOI: https://doi.org/10.3390/diagnostics14121221
IF: 3.6
2024-06-10
Diagnostics
Abstract:Optical coherence tomography (OCT) is a non-invasive imaging technique based on the principle of low-coherence interferometry that captures detailed images of ocular structures. Multiple sclerosis (MS) is a neurodegenerative disease that can lead to damage of the optic nerve and retina, which can be depicted by OCT. The purpose of this pilot study is to determine whether macular OCT can be used as a biomarker in the detection of retrochiasmal lesions of the visual pathway in MS patients. We conducted a prospective study in which we included 52 MS patients and 27 healthy controls. All participants underwent brain MRI, visual field testing, and OCT evaluation of the thicknesses of the peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell layer (GCL), and macular inner plexiform layer (IPL). OCT measurements were adjusted for optic neuritis (ON). VF demonstrated poor capability to depict a retrochiasmal lesion identified by brain MRI (PPV 0.50). In conclusion, the OCT analysis of the macula appears to excel in identifying retrochiasmal MS lesions compared to VF changes. The alterations in the GCL and IPL demonstrate the most accurate detection of retrochiasmal visual pathway changes in MS patients.
medicine, general & internal
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: to determine whether the use of **macular optical coherence tomography (macular OCT)** can be used as a biomarker for detecting post - chiasmatic visual pathway lesions in patients with multiple sclerosis (MS). Specifically, the study aims to evaluate the effectiveness of macular OCT in identifying post - chiasmatic visual pathway lesions in MS patients and compare it with the visual field test (VF) to explore its potential as a diagnostic tool. ### Research Background Multiple sclerosis is a chronic inflammatory disease of the central nervous system (CNS) that may cause damage to the optic nerve and retina. These damages can be observed by optical coherence tomography (OCT). OCT is a non - invasive imaging technique based on the principle of low - coherence interferometry and is able to capture detailed images of the ocular structures. OCT has shown great potential in detecting structural changes in the optic nerve and retina in MS patients. ### Research Objectives 1. **To evaluate the ability of macular OCT in detecting post - chiasmatic visual pathway lesions in MS patients**. 2. **To compare the effects of macular OCT and the visual field test (VF) in detecting post - chiasmatic lesions**. 3. **To explore the potential applications of macular OCT in the diagnosis and monitoring of MS**. ### Main Findings - **OCT analysis performs well in identifying post - chiasmatic MS lesions**, especially in detecting changes in the GCL (ganglion cell layer, retinal ganglion cell layer) and IPL (inner plexiform layer, inner plexiform layer). - **The visual field test (VF) performs poorly in identifying post - chiasmatic lesions confirmed by brain MRI**, with a positive predictive value (PPV) of only 0.50. - **The adjusted OCT measurements (especially IPL) have higher accuracy in detecting post - chiasmatic lesions**, with a PPV value of 0.81. ### Conclusions The research results show that macular OCT is superior to the visual field test (VF) in identifying post - chiasmatic visual pathway lesions in MS patients, especially by detecting changes in GCL and IPL. This provides a new and effective tool for the early diagnosis and disease monitoring of MS. Hope this information is helpful to you! If you have any other questions or need further explanation, please feel free to let me know.